Adrian Hondarza-Martin
Madrid, MD, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Markers of inflammation and immune dysfunction and non-AIDS cancer risk in adults with HIV.
Journal: Journal of acquired immune deficiency syndromes (1999)
Published: April 07, 2025
Humoral and cellular immune responses in people living with HIV following successive COVID-19 vaccine booster doses.
Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
Published: January 09, 2025
Lower T cell response against SARS-CoV-2 variants of concern after mRNA vaccine and risk of breakthrough infections in people with HIV.
Journal: AIDS (London, England)
Published: February 13, 2023
Impact of Previous Common Human Coronavirus Exposure on SARS-CoV-2-Specific T-Cell and Memory B-Cell Response after mRNA-Based Vaccination.
Journal: Viruses
Published: January 18, 2023
mRNA-based SARS-CoV-2 Comirnaty vaccine elicits weak and short specific memory B cell response in individuals with no previous infection.
Journal: Frontiers in immunology
Published: December 19, 2022
Impact of SARS-CoV-2-specific memory B cells on the immune response after mRNA-based Comirnaty vaccine in seronegative health care workers.
Journal: Frontiers in microbiology
Published: July 25, 2022
Cellular Responses to Membrane and Nucleocapsid Viral Proteins Are Also Boosted After SARS-CoV-2 Spike mRNA Vaccination in Individuals With Either Past Infection or Cross-Reactivity.
Journal: Frontiers in microbiology
Published: November 10, 2021
Pre-existing T cell immunity determines the frequency and magnitude of cellular immune response to two doses of mRNA vaccine against SARS-CoV-2.
Journal: Vaccine: X
Published: October 25, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026